Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

GMRE vs CHCT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
GMRE
Global Medical REIT Inc.

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$94M
5Y Perf.-33.3%
CHCT
Community Healthcare Trust Incorporated

REIT - Healthcare Facilities

Real EstateNYSE • US
Market Cap$504M
5Y Perf.-53.1%

GMRE vs CHCT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
GMRE logoGMRE
CHCT logoCHCT
IndustryREIT - Healthcare FacilitiesREIT - Healthcare Facilities
Market Cap$94M$504M
Revenue (TTM)$148M$122M
Net Income (TTM)$2M$6M
Gross Margin68.8%62.7%
Operating Margin24.9%39.8%
Forward P/E595.7x37.5x
Total Debt$654M$536M
Cash & Equiv.$7M$3M

GMRE vs CHCTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

GMRE
CHCT
StockMay 20Mar 26Return
Global Medical REIT… (GMRE)10066.7-33.3%
Community Healthcar… (CHCT)10046.9-53.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: GMRE vs CHCT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CHCT leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Global Medical REIT Inc. is the stronger pick specifically for capital preservation and lower volatility and dividend income and shareholder returns. As sector peers, any of these can serve as alternatives in the same allocation.
GMRE
Global Medical REIT Inc.
The Real Estate Income Play

GMRE is the clearest fit if your priority is income & stability and long-term compounding.

  • Dividend streak 5 yrs, beta 0.48, yield 63.5%
  • 308.1% 10Y total return vs CHCT's 81.6%
  • Lower volatility, beta 0.48, current ratio 0.03x
Best for: income & stability and long-term compounding
CHCT
Community Healthcare Trust Incorporated
The Real Estate Income Play

CHCT carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 4.7%, EPS growth 133.7%, 3Y rev CAGR 7.5%
  • 4.7% FFO/revenue growth vs GMRE's -1.8%
  • Lower P/E (37.5x vs 595.7x)
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthCHCT logoCHCT4.7% FFO/revenue growth vs GMRE's -1.8%
ValueCHCT logoCHCTLower P/E (37.5x vs 595.7x)
Quality / MarginsCHCT logoCHCT5.0% margin vs GMRE's 1.7%
Stability / SafetyGMRE logoGMREBeta 0.48 vs CHCT's 0.60, lower leverage
DividendsGMRE logoGMRE63.5% yield, 5-year raise streak, vs CHCT's 11.3%
Momentum (1Y)CHCT logoCHCT+14.4% vs GMRE's -0.7%
Efficiency (ROA)CHCT logoCHCT0.6% ROA vs GMRE's 0.2%, ROIC 1.6% vs 2.0%

GMRE vs CHCT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

GMREGlobal Medical REIT Inc.

Segment breakdown not available.

CHCTCommunity Healthcare Trust Incorporated
FY 2018
Real Estate
100.0%$6M

GMRE vs CHCT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGMRELAGGINGCHCT

Income & Cash Flow (Last 12 Months)

CHCT leads this category, winning 4 of 6 comparable metrics.

GMRE and CHCT operate at a comparable scale, with $148M and $122M in trailing revenue. Profitability is closely matched — net margins range from 5.0% (CHCT) to 1.7% (GMRE). On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricGMRE logoGMREGlobal Medical RE…CHCT logoCHCTCommunity Healthc…
RevenueTrailing 12 months$148M$122M
EBITDAEarnings before interest/tax$95M$92M
Net IncomeAfter-tax profit$2M$6M
Free Cash FlowCash after capex$19M$60M
Gross MarginGross profit ÷ Revenue+68.8%+62.7%
Operating MarginEBIT ÷ Revenue+24.9%+39.8%
Net MarginNet income ÷ Revenue+1.7%+5.0%
FCF MarginFCF ÷ Revenue+12.6%+49.5%
Rev. Growth (YoY)Latest quarter vs prior year+18.7%+4.0%
EPS Growth (YoY)Latest quarter vs prior year-166.2%+124.4%
CHCT leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

GMRE leads this category, winning 4 of 5 comparable metrics.

At 115.3x trailing earnings, GMRE trades at a 49% valuation discount to CHCT's 227.9x P/E. On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than CHCT's 16.3x.

MetricGMRE logoGMREGlobal Medical RE…CHCT logoCHCTCommunity Healthc…
Market CapShares × price$94M$504M
Enterprise ValueMkt cap + debt − cash$741M$1.0B
Trailing P/EPrice ÷ TTM EPS115.29x227.91x
Forward P/EPrice ÷ next-FY EPS est.595.67x37.53x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple8.35x16.25x
Price / SalesMarket cap ÷ Revenue0.68x4.16x
Price / BookPrice ÷ Book value/share0.17x1.10x
Price / FCFMarket cap ÷ FCF8.93x
GMRE leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

CHCT leads this category, winning 6 of 9 comparable metrics.

CHCT delivers a 1.4% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $0 for GMRE. GMRE carries lower financial leverage with a 1.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHCT's 1.25x. On the Piotroski fundamental quality scale (0–9), CHCT scores 6/9 vs GMRE's 4/9, reflecting solid financial health.

MetricGMRE logoGMREGlobal Medical RE…CHCT logoCHCTCommunity Healthc…
ROE (TTM)Return on equity+0.5%+1.4%
ROA (TTM)Return on assets+0.2%+0.6%
ROICReturn on invested capital+2.0%+1.6%
ROCEReturn on capital employed+5.3%+2.3%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage1.18x1.25x
Net DebtTotal debt minus cash$647M$533M
Cash & Equiv.Liquid assets$7M$3M
Total DebtShort + long-term debt$654M$536M
Interest CoverageEBIT ÷ Interest expense1.14x1.15x
CHCT leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

GMRE leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in GMRE five years ago would be worth $8,026 today (with dividends reinvested), compared to $5,559 for CHCT. Over the past 12 months, CHCT leads with a +14.4% total return vs GMRE's -0.7%. The 3-year compound annual growth rate (CAGR) favors GMRE at 1.5% vs CHCT's -14.0% — a key indicator of consistent wealth creation.

MetricGMRE logoGMREGlobal Medical RE…CHCT logoCHCTCommunity Healthc…
YTD ReturnYear-to-date+6.9%+10.9%
1-Year ReturnPast 12 months-0.7%+14.4%
3-Year ReturnCumulative with dividends+4.7%-36.4%
5-Year ReturnCumulative with dividends-19.7%-44.4%
10-Year ReturnCumulative with dividends+308.1%+81.6%
CAGR (3Y)Annualised 3-year return+1.5%-14.0%
GMRE leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.

GMRE is the less volatile stock with a 0.48 beta — it tends to amplify market swings less than CHCT's 0.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHCT currently trades 96.8% from its 52-week high vs GMRE's 89.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricGMRE logoGMREGlobal Medical RE…CHCT logoCHCTCommunity Healthc…
Beta (5Y)Sensitivity to S&P 5000.48x0.60x
52-Week HighHighest price in past year$39.93$18.22
52-Week LowLowest price in past year$29.05$13.23
% of 52W HighCurrent price vs 52-week peak+89.5%+96.8%
RSI (14)Momentum oscillator 0–10052.752.3
Avg Volume (50D)Average daily shares traded104K234K
Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.

Wall Street rates GMRE as "Buy" and CHCT as "Hold". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs 4.9% for CHCT (target: $19). For income investors, GMRE offers the higher dividend yield at 63.51% vs CHCT's 11.33%.

MetricGMRE logoGMREGlobal Medical RE…CHCT logoCHCTCommunity Healthc…
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$40.00$18.50
# AnalystsCovering analysts2216
Dividend YieldAnnual dividend ÷ price+63.5%+11.3%
Dividend StreakConsecutive years of raises511
Dividend / ShareAnnual DPS$22.70$2.00
Buyback YieldShare repurchases ÷ mkt cap0.0%+0.4%
Evenly matched — GMRE and CHCT each lead in 1 of 2 comparable metrics.
Key Takeaway

CHCT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GMRE leads in 2 (Valuation Metrics, Total Returns). 2 tied.

Best OverallGlobal Medical REIT Inc. (GMRE)Leads 2 of 6 categories
Loading custom metrics...

GMRE vs CHCT: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is GMRE or CHCT a better buy right now?

For growth investors, Community Healthcare Trust Incorporated (CHCT) is the stronger pick with 4.

7% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — GMRE or CHCT?

On trailing P/E, Global Medical REIT Inc.

(GMRE) is the cheapest at 115. 3x versus Community Healthcare Trust Incorporated at 227. 9x. On forward P/E, Community Healthcare Trust Incorporated is actually cheaper at 37. 5x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — GMRE or CHCT?

Over the past 5 years, Global Medical REIT Inc.

(GMRE) delivered a total return of -19. 7%, compared to -44. 4% for Community Healthcare Trust Incorporated (CHCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus CHCT's +81. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — GMRE or CHCT?

By beta (market sensitivity over 5 years), Global Medical REIT Inc.

(GMRE) is the lower-risk stock at 0. 48β versus Community Healthcare Trust Incorporated's 0. 60β — meaning CHCT is approximately 25% more volatile than GMRE relative to the S&P 500. On balance sheet safety, Global Medical REIT Inc. (GMRE) carries a lower debt/equity ratio of 118% versus 125% for Community Healthcare Trust Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — GMRE or CHCT?

By revenue growth (latest reported year), Community Healthcare Trust Incorporated (CHCT) is pulling ahead at 4.

7% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: Community Healthcare Trust Incorporated grew EPS 133. 7% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, CHCT leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — GMRE or CHCT?

Global Medical REIT Inc.

(GMRE) is the more profitable company, earning 4. 8% net margin versus 4. 2% for Community Healthcare Trust Incorporated — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus 16. 7% for CHCT. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is GMRE or CHCT more undervalued right now?

On forward earnings alone, Community Healthcare Trust Incorporated (CHCT) trades at 37.

5x forward P/E versus 595. 7x for Global Medical REIT Inc. — 558. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.

08

Which pays a better dividend — GMRE or CHCT?

All stocks in this comparison pay dividends.

Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 11. 3% for Community Healthcare Trust Incorporated (CHCT).

09

Is GMRE or CHCT better for a retirement portfolio?

For long-horizon retirement investors, Global Medical REIT Inc.

(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 48), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, CHCT: +81. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between GMRE and CHCT?

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

GMRE

High-Growth Disruptor

  • Sector: Real Estate
  • Market Cap > $100B
  • Revenue Growth > 9%
  • Gross Margin > 41%
Run This Screen
Stocks Like

CHCT

Income & Dividend Stock

  • Sector: Real Estate
  • Market Cap > $100B
  • Gross Margin > 37%
  • Dividend Yield > 4.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform GMRE and CHCT on the metrics below

Revenue Growth>
%
(GMRE: 18.7% · CHCT: 4.0%)
P/E Ratio<
x
(GMRE: 115.3x · CHCT: 227.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.